Ratings by UBS (Graham Doyle)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/15/2026 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
84.77 (74.27) |
-12.39% | Details | |
| 5/5/2025 | GE HealthCare | GEHC | Upgrade | Neutral (Sell) |
70.53 (74.27) |
5.3% | Details | |
| 9/26/2024 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
92.21 (74.27) |
-19.46% | Details | |
| 7/2/2024 | GE HealthCare | GEHC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/12/2024 | GE HealthCare | GEHC | Upgrade | Neutral (Sell) |
81.34 (92.21) |
13.36% | Details | |
| 11/27/2023 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
73.60 (74.27) |
0.91% | Details | |
| 4/26/2023 | GE HealthCare | GEHC | New Coverage | Neutral (N/A) |
87.79 (74.27) |
-15.4% | Details |
